You are here
FDA Approves Generic Labetalol for Hypertension
Labetalol hydrochloride tablets are indicated for the management of hypertension. The drug may be used alone or in combination with other antihypertensive agents, such as thiazide and loop diuretics.
Labetalol hydrochloride tablets are contraindicated in patients with bronchial asthma, overt cardiac failure, greater-than-first-degree heart block, cardiogenic shock, severe bradycardia, and other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product.
Beta blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.
Read the news release, available here.